Scripscan:Avon Organics Ltd
cmp:29
Code:531541
Story:Due to the change in product mix, introduction of new products, expansion of the capacities of existing high value products and various other cost control measures taken up by the Company, Avon has market a solid turnaround.Avon has also made strategic alliances with the co-manufacturers, which have helped the it in removing unhealthy marketing competitions.Avon succeeded in forging a strategic tie-up with Arch Pharmalabs Limited for using their Research and Development facilities for development of new products, improvement in processes of existing products, leveraging supply chain efficiencies through collaborative sourcing and increasing marketing base. All these steps initiated, will enable the Company to increase the top line substantially, in the years to come.The Company is also actively pursuing strategic partnerships with leading formulation companies both in India & abroad to expand the product portfolio at its Bio-Tech division at Solapur which has USFDA approval. The managemnet firmly believes that such tie-ups and alliances will greatly enhance its manufacturing capabilities and also place it firmly in the outsourcing opportunities.With the company coming with robust numbers quarter after quarter I feel avon shareholders would be here for merry time in near future.Buy it at 25 odd to enhance your portfolio over the medium to long term perspective.
Search This Blog(Over 800 companies covered in the blog).
Please note
Archives : Old artciles
Important Disclaimer&Privacy policy
This blog does not share personal information with third parties nor do we store any information about your visit to this blog other than to analyze and optimize your content and reading experience through the use of cookies.You can turn off the use of cookies at anytime by changing your specific browser settings.This privacy policy is subject to change without notice and was last updated on 20.3.2013. If you have any questions, feel free to contact me directly here: arunsharemarket@gmail.com
Investment in equity shares has its own risks.Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that I consider reliable. I,however,do not vouch for the accuracy or the completeness thereof.This material is for personal information and am not responsible for any loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.The stock price projections shown are not necessarily indicative of future price performance.The information herein, together with all estimates and forecasts, can change without notice.
